Atrys Health, S.A. (BME:ATRY)
3.380
+0.250 (7.99%)
Oct 7, 2025, 5:35 PM CET
Atrys Health Revenue
Atrys Health had revenue of 117.50M EUR in the half year ending June 30, 2025, with 12.60% growth. This brings the company's revenue in the last twelve months to 226.24M, up 7.17% year-over-year. In the year 2024, Atrys Health had annual revenue of 218.10M with 5.82% growth.
Revenue (ttm)
226.24M
Revenue Growth
+7.17%
P/S Ratio
1.05
Revenue / Employee
112.22K
Employees
2,045
Market Cap
237.49M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 218.10M | 12.00M | 5.82% |
Dec 31, 2023 | 206.10M | 42.90M | 26.28% |
Dec 31, 2022 | 163.20M | 39.35M | 31.77% |
Dec 31, 2021 | 123.85M | 90.04M | 266.34% |
Dec 31, 2020 | 33.81M | 17.15M | 102.95% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Grifols | 7.45B |
Laboratorios Farmaceuticos Rovi | 749.00M |
Almirall | 1.05B |
Pharma Mar | 189.27M |
Faes Farma | 543.77M |
Clínica Baviera | 288.92M |
Oryzon Genomics | 7.47M |
Laboratorio Reig Jofre | 336.87M |